Diabetes Research and Clinical Practice 2012-06-01

Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs.

Kathleen M Dungan, John B Buse, William H Herman, Richard F Arakaki, Honghua H Jiang, Jennie G Jacobson, Jessie L Fahrbach

Index: Diabetes Res. Clin. Pract. 96(3) , e66-9, (2012)

Full Text: HTML

Abstract

Endpoint HbA(1c) <7.0% was achieved by 80 (73.4%) lispro mix 25 (LM25)-treated patients and 67 (60.9%) glargine-treated patients (p=0.027) with baseline 1,5 anhydroglucitol (1,5AG) below median and 75 (70.8%) LM25-treated patients and 72 (63.7%) glargine-treated patients (p=0.238) with 1,5AG≥median, suggesting, 1,5AG may offer therapeutic insight when starting insulin therapy.Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Related Compounds

  • 1,5-Anhydrosorbito...

Related Articles:

Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.

2013-08-01

[Am. J. Clin. Nutr. 98(2) , 488-93, (2013)]

Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease.

2013-01-01

[BMC Cardiovasc. Disord. 13 , 11, (2013)]

Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study.

2012-01-01

[J. Diabetes Complications 26(1) , 34-9, (2012)]

Improved Insulin Secretion by Autologous Islet Transplantation, Compared to Oral Antidiabetic Agents, After Distal Pancreatectomy.

2015-01-01

[Cell. Transplant. 24 , 1615-26, (2015)]

A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.

2012-05-01

[Diabetes. Metab. Res. Rev. 28(4) , 357-62, (2012)]

More Articles...